Novel Insights from Clinical Practice
Midtrimester Fetal Herpes Simplex-2 Diagnosis by Serology, Culture and Quantitative Polymerase Chain ReactionCurtin W.M.a, b · Menegus M.A.c · Patru M.-M.c · Peterson C.J.b · Metlay L.A.c · Mooney R.A.c · Stanwood N.L.d, e · Scheible A.L.b · Dorgan A.b
aDivision of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Pathology, Penn State University Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pa., and bDivision of Maternal-Fetal Medicine, and Departments of cPathology and Laboratory Medicine and dObstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, N.Y., and eDepartment of Obstetrics, Gynecology and Reproductive Science, Yale School of Medicine, New Haven, Conn., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
The acquisition of herpes simplex virus (HSV) in utero comprises a minority of neonatal herpes infections. Prenatal diagnosis is rare. We describe a midtrimester diagnosis of fetal HSV-2 infection. Ultrasound at 20 weeks for elevated maternal serum α-fetoprotein (MSAFP) showed lagging fetal growth, echogenic bowel, echogenic myocardium, and liver with a mottled pattern of echogenicity. Amniocentesis demonstrated normal karyotype, elevated AFP and positive acetylcholinesterase. Culture isolated HSV-2 with an aberrant growth pattern. Maternal serology was positive for HSV-2. Quantitative DNA polymerase chain reaction (PCR) showed 59 million copies/ml. Fetal autopsy demonstrated widespread tissue necrosis but only sparse HSV-2 inclusions. Fetal HSV-2 infection can be suspected when an elevated MSAFP accompanies ultrasound findings suggesting perinatal infection. Maternal HSV serology, amniotic fluid culture and quantitative PCR are recommended for diagnostic certainty and counseling.
© 2012 S. Karger AG, Basel
- Corey L, Wald A: Maternal and neonatal HSV infections. N Engl J Med 2009;361:1376-1385.
- Brown ZA, Selke SA, Zeh J, Kopelman J, Maslow A, Ashley RL, Watts DH, Berry S, Herd M, Corey L: Acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-515.
- Morrow R, Friedrich D: Performance of a novel test for IgM and IgG antibodies in -subjects with culture-documented genital herpes simplex virus-1 or -2 infection. Clin Microbiol Infect 2006;12:463-469.
- Gupta R, Warren T, Wald A: Genital herpes. Lancet 2007;370:2127-2137.
- Lanouette JM, Duquette DA, Jacques SM, Qureshi F, Johnson MP, Berry SM: Prenatal diagnosis of fetal herpes simplex infection. Fetal Diagn Ther 1996;11:414-416.
Mitra AG, O'Malley DP, Banks PM, Kelly M: Myocardial calcification in a fetus: a distinctive presentation of in utero herpes simplex virus type II infection. J Ultrasound Med 2004;23:1385-1390.
- Diguet A, Patrier S, Eurin D, Chouchene S, Marpeau L, Laquerrière A, et al: Prenatal diagnosis of an exceptional intrauterine herpes simplex infection. Prenat Diagn 2006;26:154-155.
- Kimberlin DW: Herpes simplex virus infections of the newborn. Semin Perinatol 2007;31:19-25.
- Alanen A, Hukkanen V: Herpes simplex virus DNA in amniotic fluid without neonatal infection. Clin Infect Dis 2000;30:363-367.
- Tang JW, Lin M, Chiu L, Koay ES: Viral loads of herpes simplex virus in clinical samples - a 5-year retrospective analysis. J Med Virol 2010;82:1911-1916.
Ville Y: CMV review. Fetal Diagn Ther 2012, in press.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.